Interim Principal Financial Officer and Principal Accounting Officer Sitaram Siddharth sold 2,282 shares of Doximity, Inc. (NASDAQ: DOCS) Class A Common Stock on February 10, 2026 at $27.88 per share, for total proceeds of $63,622. The sale was processed automatically under a Rule 10b5-1 trading plan.
On the same date, Siddharth converted 5,000 shares of Class B Common Stock into Class A Common Stock. In addition, he acquired 5,000 shares through the exercise of stock options that carried an exercise price of $4.12 per share.
The sale took place while Doximity’s shares were trading at $24.28, below the sale price and close to the company’s 52-week low of $23.53. Over the past six months the stock has fallen 65.82%.
Despite the price decline, InvestingPro analysis included in available reporting indicates the shares may be undervalued at current levels. The company’s financial profile shows a gross profit margin of 89.75% and a price-to-earnings ratio of 20.51.
Market reaction and analyst positioning have been varied following Doximity’s fiscal third-quarter results. The company reported revenue and EBITDA that exceeded guidance and consensus estimates by $4.6 million and $7.9 million, respectively.
Several brokerages have updated their views in response to the quarter. BMO Capital lowered its price target on Doximity to $25 and maintained a Market Perform rating, citing near-term headwinds. Canaccord Genuity moved its rating from Hold to Buy while setting a reduced price target of $34, noting valuation concerns but attributing the recent selloff to perceived overreactions around pharmaceutical marketing budgets and disruption from AI. Mizuho also adjusted its price target to $34 while keeping a Neutral rating, pointing to delays in pharmaceutical marketing expenditures. Piper Sandler raised its price target to $42 and retained an Overweight rating after reviewing the company’s AI tool suite.
These analyst moves underscore divergent assessments of Doximity’s near-term challenges and longer-term prospects. The company’s recent financial beats contrast with concerns over marketing spend timing, valuation and the potential impact of AI-related shifts cited by analysts. At the current trading level noted above, insider activity included both divestiture under an automated plan and internal share-class conversion and option exercises by a senior finance executive.
Readers should note the specific, documented transactions and analyst commentary reported here. No additional assumptions about causation or future performance are made beyond the disclosed facts of the trades, conversions, option exercise and published analyst actions.